CTOs on the Move

Harpoon Therapeutics

www.harpoontx.com

 
Harpoon Therapeutics is a clinical-stage immuno-oncology company developing a novel class of T cell engagers that harness the power of the body`s immune system to treat patients suffering from cancer and other diseases. T cell engagers are engineered proteins that direct a patient`s own T cells to kill target cells that express specific proteins, or antigens, carried by the target cells. Using its proprietary Tri-specific T cell Activating Construct (TriTAC®) platform, Harpoon is developing a pipeline of novel TriTACs initially focused on the treatment of solid tumors and hematologic malignancies. Harpoon has also developed a proprietary ProTriTAC™ platform, which applies ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.harpoontx.com
  • 611 Gateway Boulevard Suite 400
    South San Francisco, CA USA 94080
  • Phone: 650.443.7400

Executives

Name Title Contact Details

Funding

Harpoon Therapeutics raised $45M on 05/25/2017
Harpoon Therapeutics raised $70M on 11/12/2018

Similar Companies

Medicago

Rx Biotech Specialty Pharmacy

Rx Biotech Specialty Pharmacy is a Los Angeles, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nakamir

Praxsyn

Headquartered in Irvine, California, Praxsyn works to realize the vision of medical professionals to improve the lives of patients. Mesa Pharmacy, a wholly owned subsidiary, provides doctors with an alternative to oral pain medications. Mesa focuses on providing custom compounded non-narcotic, transdermal topical pain medications that are marketed to industrial health physicians and medical clinics. Mesa has developed a series of topical creams, in different strengths, that provide the pain relief doctors seek for their patients.

Halcyon Rehabilitation

Halcyon Rehabilitation enhances the quality of life in the community we service through top tier Physical Therapy, Occupational Therapy and Speech Language Pathology focused on long term care facilities. Our population focused programs allow us to assi...